de Galan BE - Search Results

1

Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.

Fabricius TW, Verhulst CEM, Kristensen PL, Holst JJ, Tack CJ, McCrimmon RJ, Heller SR, Evans ML, de Galan BE, Pedersen-Bjergaard U; Hypo-RESOLVE consortium. Fabricius TW, et al. Among authors: de galan be. Acta Diabetol. 2024 May;61(5):623-633. doi: 10.1007/s00592-024-02239-8. Epub 2024 Feb 20. Acta Diabetol. 2024. PMID: 38376580 Free PMC article.

2

Caffeine can decrease insulin sensitivity in humans.

Keijzers GB, De Galan BE, Tack CJ, Smits P. Keijzers GB, et al. Among authors: de galan be. Diabetes Care. 2002 Feb;25(2):364-9. doi: 10.2337/diacare.25.2.364. Diabetes Care. 2002. PMID: 11815511 Clinical Trial.

3

Theophylline improves hypoglycemia unawareness in type 1 diabetes.

de Galan BE, Tack CJ, Lenders JW, Pasman JW, Elving LD, Russel FG, Lutterman JA, Smits P. de Galan BE, et al. Diabetes. 2002 Mar;51(3):790-6. doi: 10.2337/diabetes.51.3.790. Diabetes. 2002. PMID: 11872681 Clinical Trial.

4

Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia.

de Galan BE, Tack CJ, Lenders JW, Lutterman JA, Smits P. de Galan BE, et al. Clin Pharmacol Ther. 2003 Jul;74(1):77-84. doi: 10.1016/S0009-9236(03)00093-6. Clin Pharmacol Ther. 2003. PMID: 12844138 Clinical Trial.

5

Antecedent adrenaline attenuates the responsiveness to but not the release of counterregulatory hormones during subsequent hypoglycemia.

de Galan BE, Rietjens SJ, Tack CJ, van der Werf SP, Sweep CG, Lenders JW, Smits P. de Galan BE, et al. J Clin Endocrinol Metab. 2003 Nov;88(11):5462-7. doi: 10.1210/jc.2003-030407. J Clin Endocrinol Metab. 2003. PMID: 14602790 Clinical Trial.

6

Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine.

De Galan BE, Tack CJ, Willemsen JJ, Sweep CG, Smits P, Lenders JW. De Galan BE, et al. J Clin Endocrinol Metab. 2004 May;89(5):2057-61. doi: 10.1210/jc.2003-031289. J Clin Endocrinol Metab. 2004. PMID: 15126521 Free article. Clinical Trial.

7

[Treatment of patients with diabetes mellitus by means of inhaled insulin].

Simsek S, de Galan BE, Tack CJ, Heine RJ. Simsek S, et al. Among authors: de galan be. Ned Tijdschr Geneeskd. 2006 Apr 15;150(15):829-32. Ned Tijdschr Geneeskd. 2006. PMID: 16676511 Dutch.

8

Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.

de Galan BE, Schouwenberg BJ, Tack CJ, Smits P. de Galan BE, et al. Neth J Med. 2006 Sep;64(8):269-79. Neth J Med. 2006. PMID: 16990690 Free article. Review.

9

Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus.

de Galan BE, Simsek S, Tack CJ, Heine RJ. de Galan BE, et al. Neth J Med. 2006 Oct;64(9):319-25. Neth J Med. 2006. PMID: 17057268 Free article. Review.

10

The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus.

Schouwenberg BJ, Veldman BA, Spiering W, Coenen MJ, Franke B, Tack CJ, de Galan BE, Smits P. Schouwenberg BJ, et al. Among authors: de galan be. Pharmacogenet Genomics. 2008 Apr;18(4):369-72. doi: 10.1097/FPC.0b013e3282f70481. Pharmacogenet Genomics. 2008. PMID: 18334922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page